CORT - Corcept Therapeutics Inc
IEX Last Trade
35.285
0.145 0.411%
Share volume: 689,637
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$35.14
0.15
0.41%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-28 | 2023-05-03 | 2023-08-02 | 2023-11-01 | 2024-02-15 | 2024-05-01 | 2024-07-29 | |
| Assets | |||||||||
| Total Assets | 533.255 M | 583.430 M | 617.848 M | 524.625 M | 594.022 M | 621.517 M | 655.935 M | 714.555 M | |
| Current Assets | 452.402 M | 499.253 M | 533.893 M | 432.588 M | 431.527 M | 458.636 M | 503.367 M | 560.846 M | |
| Inventories | 6.046 M | 6.100 M | 6.409 M | 6.915 M | 7.513 M | 7.730 M | 7.190 M | 8.350 M | |
| Other Current Assets | 20.680 M | 30.424 M | 29.870 M | 29.858 M | 34.163 M | 41.562 M | 23.898 M | 25.503 M | |
| Short Term Investments | 20.680 M | 30.424 M | 29.870 M | 29.858 M | 34.163 M | 41.562 M | 23.898 M | 25.503 M | |
| Total Receivables | 29.414 M | 31.057 M | 32.557 M | 32.553 M | 34.626 M | 41.123 M | 61.518 M | 53.837 M | |
| Current Cash | 396.262 M | 431.672 M | 465.057 M | 363.262 M | 355.225 M | 368.221 M | 410.761 M | 473.156 M | |
| Total Non-current Assets | 80.853 M | 84.177 M | 83.955 M | 92.037 M | 162.495 M | 162.881 M | 152.568 M | 153.709 M | |
| Property Plant Equipment | 801.000 K | 633.000 K | 461.000 K | 413.000 K | 302.000 K | 195.000 K | 127.000 K | 1.472 M | |
| Other Assets | 16.108 M | 15.989 M | 14.920 M | 13.175 M | 15.292 M | 14.785 M | 14.234 M | 15.390 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 533.255 M | 583.430 M | 617.848 M | 524.625 M | 594.022 M | 621.517 M | 655.935 M | 714.555 M | |
| Total liabilities | 59.891 M | 81.588 M | 88.264 M | 103.011 M | 132.343 M | 114.812 M | 108.071 M | 118.312 M | |
| Total current liabilities | 53.068 M | 72.491 M | 78.865 M | 93.059 M | 121.873 M | 104.505 M | 97.202 M | 100.750 M | |
| Accounts Payable | 8.178 M | 11.976 M | 11.216 M | 7.976 M | 16.710 M | 17.396 M | 12.557 M | 19.484 M | |
| Other liabilities | 6.823 M | 9.097 M | 9.399 M | 9.952 M | 10.470 M | 10.307 M | 10.869 M | 11.937 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 6.823 M | 9.097 M | 9.399 M | 9.952 M | 10.470 M | 10.307 M | 10.869 M | 11.937 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 473.364 M | 501.842 M | 529.584 M | 421.614 M | 461.679 M | 506.705 M | 547.864 M | 596.243 M | |
| Common stock | 107.125 M | 107.722 M | 107.885 M | 101.964 M | 102.014 M | 102.377 M | 102.791 M | 103.118 M | |
| Retained earnings | 279.785 M | 296.386 M | 312.265 M | 339.793 M | 371.171 M | 402.526 M | 430.288 M | 465.776 M |